Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Sell
30
RXRX Quote, Financials, Valuation and Earnings
Last price:
$5.75
Seasonality move
:
6.71%
Day range:
$4.86 - $6.00
52-week range:
$3.79 - $12.36
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
27.02x
P/B ratio:
2.24x
Volume:
83.4M
Avg. volume:
22M
1-year change:
-35.43%
Market cap:
$2.3B
Revenue:
$58.5M
EPS (TTM):
-$1.66
RXRX Analysts' Consensus Rating
The 7 analysts providing 12-month price projections for Recursion Pharmaceuticals shares anticipate an average target of $8.71, ranging from a low estimate of $6.00 to a high estimate of $11.00. This average target implies a growth of 51.29% compared to the current stock price of $5.76.
Consensus Price Target
$8.71
Highest Price Target
$11.00
Lowest Price Target
$6.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 1 | 1 | 1 |
| Hold | 6 | 6 | 6 |
| Sell | 0 | 0 | 0 |
| Consensus | Hold | Hold | Hold |
RXRX Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Is Bloom Energy Stock a Buy, Sell or Hold?
While already interesting as the world moves toward greener energy…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
